Krishna Tissues Profile
Key Indicators
- Authorised Capital ₹ 56.00 Cr
- Paid Up Capital ₹ 17.97 Cr
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 615.31 Cr
- Satisfied Charges ₹ 1,620.79 Cr
- Revenue Growth 68.83%
- Profit Growth 89.89%
- Ebitda 27.19%
- Net Worth 16.31%
- Total Assets 11.99%
About Krishna Tissues
Krishna Tissues Private Limited (KTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 March 2005 and has a history of 19 years and ten months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 56.00 Cr and a paid-up capital of Rs 17.97 Cr.
The company currently has active open charges totaling ₹615.31 Cr. The company has closed loans amounting to ₹1,620.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Krishna Tissues Private Limited India is Shyam Agarwal as COMPANY SECRETARY. Jyoti Bajaj, Kanti Bajaj, Kishore Sinha, and Three other members serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U21093WB2005PTC102564
- Company No.
102564
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Krishna Tissues?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shyam Agarwal ![]() | Company Secretary | 01-Jul-2015 | Current |
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jyoti Bajaj ![]() | Director | 30-Mar-2005 | Current |
Kanti Bajaj ![]() | Director | 30-Mar-2005 | Current |
Kishore Sinha ![]() | Director | 04-Oct-2009 | Current |
Golam Ali ![]() | Director | 01-Sep-2015 | Current |
Prakash Kanodia ![]() | Director | 01-Mar-2021 | Current |
Sanjay Bhadury ![]() | Director | 14-Jan-2016 | Current |
Financial Performance of Krishna Tissues.
Krishna Tissues Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.83% increase. The company also saw a substantial improvement in profitability, with a 89.89% increase in profit. The company's net worth Soared by an impressive increase of 16.31%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Krishna Tissues?
In 2023, Krishna Tissues had a promoter holding of 86.08% and a public holding of 13.92%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹615.31 Cr
₹1,620.79 Cr
Charges Breakdown by Lending Institutions
- Others : 480.29 Cr
- Indian Bank : 132.32 Cr
- Axis Bank Limited : 1.55 Cr
- Hdfc Bank Limited : 1.16 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
03 Aug 2024 | Others | ₹7.00 Cr | Open |
30 Jul 2022 | Others | ₹1.68 Cr | Open |
29 Apr 2022 | Axis Bank Limited | ₹3.07 M | Open |
30 Mar 2022 | Others | ₹6.05 M | Open |
30 Aug 2021 | Axis Bank Limited | ₹2.89 M | Open |
How Many Employees Work at Krishna Tissues?
Krishna Tissues has a workforce of 729 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Krishna Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krishna Tissues's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.